The evolution of assays for immuno-oncology research
Drug Discovery World
FEBRUARY 15, 2023
The first such research dates back to 1891, when William Coley attempted to inject heat-inactivated bacteria to treat osteosarcoma. Genetically modified T cells stimulated with IL2 are now administered as cell therapy for multiple cancer cell types with beneficial results 3,4. EMBO Mol Med 2017;9:137–53.doi:10.15252/emmm.201606857pmid:[link]
52 
Let's personalize your content